| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Data Interpretation, Statistical | 8 | 2021 | 195 | 2.180 |
Why?
|
| Epidemiologic Studies | 5 | 2023 | 34 | 2.160 |
Why?
|
| Menopause, Premature | 5 | 2022 | 26 | 2.000 |
Why?
|
| Pregnancy | 50 | 2025 | 2432 | 1.980 |
Why?
|
| Cancer Survivors | 11 | 2024 | 127 | 1.960 |
Why?
|
| Diabetes, Gestational | 8 | 2025 | 143 | 1.870 |
Why?
|
| Menstrual Cycle | 11 | 2025 | 83 | 1.810 |
Why?
|
| Bias | 8 | 2024 | 116 | 1.750 |
Why?
|
| Menopause | 14 | 2024 | 261 | 1.680 |
Why?
|
| Live Birth | 8 | 2024 | 21 | 1.670 |
Why?
|
| Anti-Mullerian Hormone | 10 | 2022 | 68 | 1.520 |
Why?
|
| Infertility, Female | 4 | 2024 | 48 | 1.500 |
Why?
|
| Progesterone | 8 | 2017 | 168 | 1.450 |
Why?
|
| Birth Weight | 8 | 2022 | 86 | 1.430 |
Why?
|
| Fertilization in Vitro | 12 | 2022 | 85 | 1.400 |
Why?
|
| Female | 124 | 2025 | 34115 | 1.390 |
Why?
|
| Adult | 91 | 2025 | 17411 | 1.350 |
Why?
|
| Biomarkers | 18 | 2024 | 1473 | 1.340 |
Why?
|
| Reproductive Techniques, Assisted | 6 | 2021 | 34 | 1.330 |
Why?
|
| Prospective Studies | 39 | 2025 | 3355 | 1.330 |
Why?
|
| Reproduction | 7 | 2021 | 100 | 1.300 |
Why?
|
| Abortion, Spontaneous | 8 | 2025 | 31 | 1.290 |
Why?
|
| Risk Factors | 41 | 2025 | 5441 | 1.270 |
Why?
|
| Humans | 141 | 2025 | 65536 | 1.220 |
Why?
|
| Reproductive Health | 3 | 2021 | 25 | 1.210 |
Why?
|
| Infertility | 6 | 2023 | 32 | 1.150 |
Why?
|
| Logistic Models | 8 | 2020 | 1282 | 1.120 |
Why?
|
| Exercise | 13 | 2024 | 964 | 1.120 |
Why?
|
| Models, Statistical | 10 | 2020 | 312 | 1.100 |
Why?
|
| Young Adult | 46 | 2025 | 4832 | 1.080 |
Why?
|
| Case-Control Studies | 12 | 2019 | 1156 | 1.080 |
Why?
|
| Oocyte Retrieval | 5 | 2017 | 15 | 1.060 |
Why?
|
| Fertility Agents, Female | 4 | 2017 | 6 | 1.050 |
Why?
|
| Neoplasms | 15 | 2024 | 1415 | 1.030 |
Why?
|
| Premenstrual Syndrome | 9 | 2019 | 100 | 1.030 |
Why?
|
| Luteinizing Hormone | 6 | 2014 | 102 | 1.030 |
Why?
|
| Ovarian Reserve | 3 | 2022 | 9 | 1.030 |
Why?
|
| Pregnancy Outcome | 11 | 2025 | 203 | 0.980 |
Why?
|
| Ovulation Induction | 3 | 2017 | 14 | 0.980 |
Why?
|
| Spermatozoa | 9 | 2022 | 265 | 0.920 |
Why?
|
| Fertility | 8 | 2024 | 84 | 0.900 |
Why?
|
| Cohort Studies | 23 | 2025 | 2632 | 0.890 |
Why?
|
| Follicle Stimulating Hormone | 8 | 2021 | 86 | 0.890 |
Why?
|
| Aspirin | 6 | 2020 | 172 | 0.860 |
Why?
|
| Odds Ratio | 12 | 2021 | 764 | 0.850 |
Why?
|
| Cytokines | 3 | 2015 | 956 | 0.840 |
Why?
|
| Phthalic Acids | 6 | 2025 | 41 | 0.820 |
Why?
|
| Adolescent | 35 | 2024 | 6378 | 0.820 |
Why?
|
| Epidemiologic Methods | 2 | 2020 | 67 | 0.800 |
Why?
|
| Fertility Preservation | 6 | 2024 | 11 | 0.760 |
Why?
|
| Chemokines | 3 | 2014 | 97 | 0.740 |
Why?
|
| Research Design | 5 | 2021 | 585 | 0.700 |
Why?
|
| Selection Bias | 2 | 2024 | 23 | 0.690 |
Why?
|
| Confidence Intervals | 2 | 2020 | 239 | 0.650 |
Why?
|
| Premature Birth | 4 | 2025 | 120 | 0.650 |
Why?
|
| Disease | 1 | 2020 | 27 | 0.640 |
Why?
|
| Infertility, Male | 4 | 2022 | 58 | 0.630 |
Why?
|
| Inflammation Mediators | 2 | 2019 | 180 | 0.630 |
Why?
|
| Environmental Pollutants | 4 | 2025 | 97 | 0.620 |
Why?
|
| Receptors, Tumor Necrosis Factor, Type II | 2 | 2019 | 29 | 0.610 |
Why?
|
| Estradiol | 6 | 2014 | 262 | 0.580 |
Why?
|
| Fetal Macrosomia | 2 | 2015 | 13 | 0.580 |
Why?
|
| Cigarette Smoking | 2 | 2021 | 58 | 0.570 |
Why?
|
| Women's Health | 6 | 2022 | 376 | 0.570 |
Why?
|
| Oocytes | 2 | 2017 | 201 | 0.540 |
Why?
|
| Smoking | 5 | 2018 | 866 | 0.540 |
Why?
|
| Age Factors | 16 | 2024 | 1592 | 0.530 |
Why?
|
| Epidemiology | 1 | 2017 | 6 | 0.530 |
Why?
|
| Survivors | 7 | 2023 | 184 | 0.510 |
Why?
|
| Biology | 1 | 2017 | 26 | 0.510 |
Why?
|
| Periodontitis | 1 | 2016 | 15 | 0.500 |
Why?
|
| Semen | 4 | 2022 | 50 | 0.480 |
Why?
|
| Pregnancy Rate | 8 | 2019 | 31 | 0.480 |
Why?
|
| Ovulation | 2 | 2014 | 29 | 0.470 |
Why?
|
| Hot Flashes | 3 | 2024 | 103 | 0.470 |
Why?
|
| DNA, Mitochondrial | 4 | 2020 | 88 | 0.470 |
Why?
|
| Statistics as Topic | 1 | 2016 | 148 | 0.460 |
Why?
|
| ROC Curve | 4 | 2018 | 295 | 0.450 |
Why?
|
| Alcohol Drinking | 2 | 2021 | 322 | 0.440 |
Why?
|
| Granulocyte Colony-Stimulating Factor | 3 | 2010 | 41 | 0.440 |
Why?
|
| Cross-Sectional Studies | 15 | 2022 | 2699 | 0.430 |
Why?
|
| Gestational Age | 4 | 2018 | 199 | 0.430 |
Why?
|
| Middle Aged | 25 | 2024 | 18262 | 0.420 |
Why?
|
| Proportional Hazards Models | 7 | 2024 | 741 | 0.410 |
Why?
|
| Endometriosis | 3 | 2022 | 28 | 0.410 |
Why?
|
| Anovulation | 3 | 2025 | 10 | 0.410 |
Why?
|
| Limit of Detection | 2 | 2010 | 46 | 0.400 |
Why?
|
| Premenopause | 4 | 2022 | 61 | 0.400 |
Why?
|
| Risk Assessment | 8 | 2024 | 2101 | 0.400 |
Why?
|
| Health Surveys | 1 | 2014 | 318 | 0.400 |
Why?
|
| Abortion, Habitual | 2 | 2018 | 8 | 0.390 |
Why?
|
| Diet | 6 | 2019 | 539 | 0.380 |
Why?
|
| Infant Mortality | 2 | 2009 | 21 | 0.380 |
Why?
|
| Aging | 3 | 2022 | 766 | 0.380 |
Why?
|
| Infant, Premature | 3 | 2013 | 199 | 0.380 |
Why?
|
| Folic Acid | 2 | 2017 | 43 | 0.380 |
Why?
|
| Smoking Cessation | 1 | 2018 | 558 | 0.380 |
Why?
|
| Restaurants | 1 | 2012 | 12 | 0.370 |
Why?
|
| Extracellular Vesicles | 2 | 2023 | 48 | 0.370 |
Why?
|
| Autistic Disorder | 1 | 2014 | 152 | 0.370 |
Why?
|
| Parity | 3 | 2021 | 71 | 0.370 |
Why?
|
| Embryo Transfer | 3 | 2016 | 25 | 0.370 |
Why?
|
| Sleep | 2 | 2025 | 239 | 0.360 |
Why?
|
| Transients and Migrants | 1 | 2012 | 26 | 0.360 |
Why?
|
| Longitudinal Studies | 7 | 2024 | 1287 | 0.360 |
Why?
|
| HIV Seropositivity | 1 | 2012 | 83 | 0.360 |
Why?
|
| Maternal Exposure | 2 | 2025 | 43 | 0.350 |
Why?
|
| Vitamins | 3 | 2017 | 81 | 0.350 |
Why?
|
| Breast Feeding | 3 | 2021 | 162 | 0.350 |
Why?
|
| Cardiovascular Diseases | 6 | 2024 | 866 | 0.350 |
Why?
|
| Sex Hormone-Binding Globulin | 1 | 2010 | 17 | 0.330 |
Why?
|
| Sexual Behavior | 1 | 2012 | 193 | 0.330 |
Why?
|
| Paternal Age | 1 | 2010 | 2 | 0.330 |
Why?
|
| Epidemiologic Research Design | 1 | 2010 | 3 | 0.330 |
Why?
|
| Oocyte Donation | 1 | 2010 | 7 | 0.330 |
Why?
|
| Self Report | 5 | 2019 | 392 | 0.330 |
Why?
|
| United States | 16 | 2024 | 8131 | 0.320 |
Why?
|
| Breast Neoplasms | 4 | 2024 | 1229 | 0.320 |
Why?
|
| Immunoassay | 1 | 2010 | 71 | 0.320 |
Why?
|
| Primary Ovarian Insufficiency | 2 | 2021 | 8 | 0.310 |
Why?
|
| Asthma | 1 | 2014 | 472 | 0.310 |
Why?
|
| Chromatography, High Pressure Liquid | 1 | 2010 | 235 | 0.310 |
Why?
|
| Insulin Resistance | 3 | 2024 | 413 | 0.310 |
Why?
|
| Infant, Newborn | 9 | 2025 | 1451 | 0.300 |
Why?
|
| Embryonic Development | 4 | 2021 | 141 | 0.300 |
Why?
|
| Semen Analysis | 4 | 2023 | 20 | 0.300 |
Why?
|
| Causality | 3 | 2020 | 59 | 0.300 |
Why?
|
| Cyclooxygenase Inhibitors | 1 | 2009 | 45 | 0.300 |
Why?
|
| Pregnancy Trimester, Second | 1 | 2009 | 37 | 0.290 |
Why?
|
| Obstetric Labor, Premature | 1 | 2009 | 31 | 0.290 |
Why?
|
| Treatment Outcome | 10 | 2024 | 5818 | 0.290 |
Why?
|
| Antineoplastic Agents | 3 | 2024 | 682 | 0.280 |
Why?
|
| Dietary Proteins | 2 | 2019 | 45 | 0.280 |
Why?
|
| Cryopreservation | 2 | 2008 | 30 | 0.280 |
Why?
|
| Retrospective Studies | 10 | 2024 | 6880 | 0.280 |
Why?
|
| Body Mass Index | 9 | 2024 | 888 | 0.280 |
Why?
|
| Obesity | 8 | 2024 | 1269 | 0.270 |
Why?
|
| Creatinine | 2 | 2021 | 134 | 0.270 |
Why?
|
| Multivariate Analysis | 4 | 2019 | 938 | 0.270 |
Why?
|
| Calcium | 2 | 2017 | 589 | 0.270 |
Why?
|
| Male | 27 | 2023 | 31067 | 0.270 |
Why?
|
| Thrombopoietin | 1 | 2007 | 11 | 0.270 |
Why?
|
| Dietary Fats | 2 | 2019 | 178 | 0.260 |
Why?
|
| DNA Methylation | 2 | 2021 | 304 | 0.260 |
Why?
|
| Predictive Value of Tests | 4 | 2018 | 1114 | 0.260 |
Why?
|
| Contraception Behavior | 2 | 2019 | 37 | 0.260 |
Why?
|
| Interleukin-6 | 3 | 2019 | 325 | 0.250 |
Why?
|
| Pregnancy Complications | 4 | 2020 | 392 | 0.250 |
Why?
|
| Health Status Indicators | 1 | 2007 | 94 | 0.250 |
Why?
|
| Ovarian Neoplasms | 2 | 2024 | 168 | 0.250 |
Why?
|
| Vitamin D | 2 | 2018 | 140 | 0.250 |
Why?
|
| Nurses | 4 | 2024 | 108 | 0.250 |
Why?
|
| Prednisone | 1 | 2006 | 86 | 0.250 |
Why?
|
| Surveys and Questionnaires | 13 | 2024 | 2781 | 0.250 |
Why?
|
| Dose-Response Relationship, Drug | 6 | 2018 | 881 | 0.250 |
Why?
|
| C-Reactive Protein | 3 | 2019 | 167 | 0.240 |
Why?
|
| MicroRNAs | 2 | 2023 | 711 | 0.240 |
Why?
|
| Stress, Psychological | 4 | 2021 | 484 | 0.240 |
Why?
|
| Feeding Behavior | 2 | 2018 | 265 | 0.230 |
Why?
|
| Maternal-Fetal Exchange | 1 | 2025 | 32 | 0.230 |
Why?
|
| Postpartum Period | 2 | 2024 | 197 | 0.230 |
Why?
|
| Hyperglycemia | 1 | 2005 | 105 | 0.220 |
Why?
|
| Heterosexuality | 1 | 2024 | 10 | 0.220 |
Why?
|
| Semen Preservation | 1 | 2004 | 6 | 0.220 |
Why?
|
| Overweight | 2 | 2024 | 255 | 0.210 |
Why?
|
| Prevalence | 6 | 2018 | 1441 | 0.210 |
Why?
|
| Menarche | 3 | 2021 | 37 | 0.210 |
Why?
|
| Patient Admission | 1 | 2005 | 199 | 0.210 |
Why?
|
| Dietary Fiber | 2 | 2018 | 79 | 0.200 |
Why?
|
| Reproductive Behavior | 2 | 2020 | 4 | 0.200 |
Why?
|
| Sensitivity and Specificity | 3 | 2020 | 1172 | 0.200 |
Why?
|
| Sexual and Gender Minorities | 2 | 2024 | 74 | 0.200 |
Why?
|
| Emotions | 2 | 2017 | 229 | 0.200 |
Why?
|
| Pre-Eclampsia | 2 | 2022 | 70 | 0.200 |
Why?
|
| RNA, Small Untranslated | 1 | 2023 | 19 | 0.200 |
Why?
|
| Risk | 3 | 2017 | 382 | 0.190 |
Why?
|
| Cholesterol | 1 | 2004 | 263 | 0.190 |
Why?
|
| Embryo Implantation | 4 | 2012 | 23 | 0.190 |
Why?
|
| Socioeconomic Factors | 6 | 2021 | 800 | 0.190 |
Why?
|
| Mitochondria | 2 | 2018 | 404 | 0.190 |
Why?
|
| National Institute of Child Health and Human Development (U.S.) | 1 | 2022 | 5 | 0.190 |
Why?
|
| Contraception | 3 | 2021 | 71 | 0.190 |
Why?
|
| Intensive Care Units | 1 | 2005 | 423 | 0.190 |
Why?
|
| Environmental Exposure | 4 | 2023 | 222 | 0.180 |
Why?
|
| Fetal Development | 1 | 2022 | 16 | 0.180 |
Why?
|
| Urinary Incontinence | 1 | 2022 | 44 | 0.180 |
Why?
|
| Diethylstilbestrol | 1 | 2022 | 51 | 0.180 |
Why?
|
| Alcoholic Beverages | 1 | 2021 | 7 | 0.180 |
Why?
|
| Sterilization, Tubal | 1 | 2021 | 11 | 0.180 |
Why?
|
| Dairy Products | 2 | 2019 | 17 | 0.180 |
Why?
|
| Reproductive Health Services | 1 | 2021 | 13 | 0.180 |
Why?
|
| Sleep Wake Disorders | 1 | 2022 | 76 | 0.170 |
Why?
|
| Interleukin-8 | 2 | 2015 | 94 | 0.170 |
Why?
|
| Circadian Rhythm | 1 | 2025 | 390 | 0.170 |
Why?
|
| Endocrine Glands | 1 | 2021 | 6 | 0.170 |
Why?
|
| DNA Copy Number Variations | 2 | 2019 | 74 | 0.170 |
Why?
|
| Life Style | 4 | 2024 | 320 | 0.170 |
Why?
|
| Hospital Mortality | 1 | 2005 | 879 | 0.170 |
Why?
|
| Cadmium | 1 | 2021 | 12 | 0.170 |
Why?
|
| Computer Simulation | 4 | 2012 | 487 | 0.170 |
Why?
|
| Lupus Erythematosus, Systemic | 1 | 2022 | 172 | 0.170 |
Why?
|
| Time Factors | 8 | 2024 | 3788 | 0.170 |
Why?
|
| Racism | 1 | 2022 | 92 | 0.170 |
Why?
|
| Colorectal Neoplasms | 1 | 2024 | 281 | 0.170 |
Why?
|
| Follow-Up Studies | 7 | 2021 | 2511 | 0.170 |
Why?
|
| Health Behavior | 4 | 2018 | 482 | 0.160 |
Why?
|
| Eating | 2 | 2019 | 140 | 0.160 |
Why?
|
| Prenatal Exposure Delayed Effects | 1 | 2022 | 160 | 0.160 |
Why?
|
| Reproductive Medicine | 1 | 2020 | 5 | 0.160 |
Why?
|
| Ovarian Follicle | 2 | 2012 | 39 | 0.160 |
Why?
|
| Randomized Controlled Trials as Topic | 3 | 2015 | 801 | 0.160 |
Why?
|
| Reference Values | 3 | 2015 | 331 | 0.160 |
Why?
|
| Insurance, Health | 1 | 2021 | 152 | 0.160 |
Why?
|
| RNA, Long Noncoding | 1 | 2022 | 172 | 0.160 |
Why?
|
| Preconception Care | 1 | 2020 | 23 | 0.160 |
Why?
|
| Meta-Analysis as Topic | 3 | 2009 | 78 | 0.160 |
Why?
|
| Comorbidity | 3 | 2023 | 1123 | 0.160 |
Why?
|
| Interferon-gamma | 2 | 2015 | 582 | 0.150 |
Why?
|
| Incidence | 6 | 2020 | 1410 | 0.150 |
Why?
|
| Rural Population | 1 | 2021 | 226 | 0.150 |
Why?
|
| Algorithms | 3 | 2018 | 1049 | 0.150 |
Why?
|
| Tumor Necrosis Factor-alpha | 2 | 2015 | 623 | 0.150 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 2 | 2013 | 205 | 0.150 |
Why?
|
| Menstruation Disturbances | 1 | 2018 | 18 | 0.140 |
Why?
|
| Suicide | 1 | 2020 | 142 | 0.140 |
Why?
|
| Massachusetts | 7 | 2024 | 2149 | 0.140 |
Why?
|
| Sperm Motility | 1 | 2018 | 50 | 0.140 |
Why?
|
| Child | 6 | 2022 | 4681 | 0.140 |
Why?
|
| Contraception, Postcoital | 1 | 2018 | 4 | 0.140 |
Why?
|
| Inflammation | 3 | 2015 | 1186 | 0.140 |
Why?
|
| Depression | 2 | 2015 | 916 | 0.140 |
Why?
|
| Pregnancy Complications, Neoplastic | 1 | 2018 | 13 | 0.140 |
Why?
|
| Perception | 1 | 2019 | 183 | 0.140 |
Why?
|
| Nutritional Status | 1 | 2018 | 99 | 0.140 |
Why?
|
| Data Accuracy | 1 | 2018 | 31 | 0.140 |
Why?
|
| Dietary Carbohydrates | 1 | 2018 | 62 | 0.130 |
Why?
|
| Public Health Surveillance | 1 | 2017 | 28 | 0.130 |
Why?
|
| Calcium, Dietary | 1 | 2017 | 29 | 0.130 |
Why?
|
| Natural Language Processing | 1 | 2018 | 52 | 0.130 |
Why?
|
| Paternal Exposure | 1 | 2016 | 6 | 0.130 |
Why?
|
| Adoption | 1 | 2016 | 5 | 0.130 |
Why?
|
| Area Under Curve | 1 | 2017 | 150 | 0.120 |
Why?
|
| Pandemics | 1 | 2021 | 676 | 0.120 |
Why?
|
| Referral and Consultation | 1 | 2020 | 434 | 0.120 |
Why?
|
| Observational Studies as Topic | 1 | 2016 | 66 | 0.120 |
Why?
|
| Survival Rate | 4 | 2017 | 861 | 0.120 |
Why?
|
| Fatty Acids | 1 | 2017 | 205 | 0.120 |
Why?
|
| Blood Pressure | 2 | 2016 | 526 | 0.120 |
Why?
|
| Trinucleotide Repeats | 1 | 2016 | 18 | 0.120 |
Why?
|
| Models, Biological | 2 | 2020 | 1217 | 0.120 |
Why?
|
| Walking | 1 | 2018 | 241 | 0.120 |
Why?
|
| Decision Making | 3 | 2020 | 420 | 0.120 |
Why?
|
| Counseling | 1 | 2018 | 378 | 0.120 |
Why?
|
| Endocrine Disruptors | 1 | 2016 | 78 | 0.120 |
Why?
|
| Mouth Diseases | 1 | 2015 | 14 | 0.120 |
Why?
|
| Sperm Count | 3 | 2020 | 15 | 0.120 |
Why?
|
| Behavioral Risk Factor Surveillance System | 1 | 2015 | 45 | 0.110 |
Why?
|
| Prognosis | 4 | 2021 | 1793 | 0.110 |
Why?
|
| Interleukin-5 | 1 | 2015 | 39 | 0.110 |
Why?
|
| Health Promotion | 2 | 2017 | 518 | 0.110 |
Why?
|
| Interleukin-7 | 1 | 2015 | 29 | 0.110 |
Why?
|
| Interleukin-13 | 1 | 2015 | 38 | 0.110 |
Why?
|
| Granulocyte-Macrophage Colony-Stimulating Factor | 1 | 2015 | 72 | 0.110 |
Why?
|
| Interleukin-4 | 1 | 2015 | 148 | 0.110 |
Why?
|
| Interleukin-12 | 1 | 2015 | 128 | 0.110 |
Why?
|
| Myelin Sheath | 1 | 2014 | 37 | 0.110 |
Why?
|
| Health Knowledge, Attitudes, Practice | 1 | 2020 | 771 | 0.110 |
Why?
|
| Interleukin-2 | 1 | 2015 | 167 | 0.110 |
Why?
|
| Oral Health | 1 | 2015 | 64 | 0.110 |
Why?
|
| Ovulation Detection | 1 | 2014 | 4 | 0.110 |
Why?
|
| Tobacco Smoke Pollution | 1 | 2014 | 57 | 0.110 |
Why?
|
| Electronic Health Records | 1 | 2018 | 384 | 0.110 |
Why?
|
| Domestic Violence | 1 | 2014 | 40 | 0.110 |
Why?
|
| Crime Victims | 1 | 2014 | 35 | 0.100 |
Why?
|
| Binge Drinking | 1 | 2014 | 38 | 0.100 |
Why?
|
| Interleukin-10 | 1 | 2015 | 164 | 0.100 |
Why?
|
| Sex Offenses | 1 | 2014 | 46 | 0.100 |
Why?
|
| Antidepressive Agents | 1 | 2015 | 230 | 0.100 |
Why?
|
| Stress Disorders, Post-Traumatic | 1 | 2018 | 407 | 0.100 |
Why?
|
| Prefrontal Cortex | 1 | 2014 | 126 | 0.100 |
Why?
|
| Insemination, Artificial | 1 | 2013 | 4 | 0.100 |
Why?
|
| Luteal Phase | 1 | 2013 | 28 | 0.100 |
Why?
|
| Hypertension | 2 | 2016 | 613 | 0.100 |
Why?
|
| Interleukin-1beta | 1 | 2015 | 273 | 0.100 |
Why?
|
| Labor Stage, Second | 1 | 2013 | 5 | 0.100 |
Why?
|
| White Matter | 1 | 2014 | 125 | 0.100 |
Why?
|
| Labor Presentation | 1 | 2013 | 3 | 0.100 |
Why?
|
| Adult Survivors of Child Abuse | 1 | 2012 | 13 | 0.100 |
Why?
|
| Infant, Premature, Diseases | 1 | 2013 | 50 | 0.090 |
Why?
|
| Delivery, Obstetric | 2 | 2013 | 56 | 0.090 |
Why?
|
| Namibia | 1 | 2012 | 1 | 0.090 |
Why?
|
| Veterans | 1 | 2020 | 799 | 0.090 |
Why?
|
| Cerebral Hemorrhage | 1 | 2013 | 100 | 0.090 |
Why?
|
| Mendelian Randomization Analysis | 1 | 2012 | 12 | 0.090 |
Why?
|
| Bilirubin | 1 | 2012 | 19 | 0.090 |
Why?
|
| Metabolic Syndrome | 2 | 2024 | 147 | 0.090 |
Why?
|
| Calcinosis | 2 | 2003 | 86 | 0.090 |
Why?
|
| Evidence-Based Medicine | 2 | 2012 | 468 | 0.090 |
Why?
|
| Anxiety | 1 | 2015 | 438 | 0.090 |
Why?
|
| Adiposity | 2 | 2022 | 85 | 0.090 |
Why?
|
| Sexual Partners | 1 | 2012 | 76 | 0.090 |
Why?
|
| Fertilization | 1 | 2012 | 84 | 0.090 |
Why?
|
| Social Class | 1 | 2012 | 139 | 0.090 |
Why?
|
| Risk-Taking | 1 | 2012 | 161 | 0.090 |
Why?
|
| Alcoholism | 1 | 2014 | 328 | 0.090 |
Why?
|
| Ethanol | 1 | 2014 | 330 | 0.090 |
Why?
|
| Reproducibility of Results | 2 | 2007 | 1700 | 0.080 |
Why?
|
| Time-to-Pregnancy | 2 | 2022 | 3 | 0.080 |
Why?
|
| Drug Therapy, Combination | 1 | 2012 | 473 | 0.080 |
Why?
|
| Calibration | 1 | 2010 | 67 | 0.080 |
Why?
|
| Hypertension, Pregnancy-Induced | 1 | 2011 | 50 | 0.080 |
Why?
|
| Genotype | 1 | 2012 | 679 | 0.080 |
Why?
|
| Age Distribution | 1 | 2010 | 259 | 0.080 |
Why?
|
| Motor Activity | 1 | 2012 | 346 | 0.080 |
Why?
|
| Recombinant Proteins | 1 | 2012 | 713 | 0.080 |
Why?
|
| Diabetes Mellitus | 2 | 2005 | 555 | 0.070 |
Why?
|
| Serum | 1 | 2009 | 28 | 0.070 |
Why?
|
| Child, Preschool | 1 | 2014 | 2077 | 0.070 |
Why?
|
| Polychlorinated Biphenyls | 2 | 2008 | 39 | 0.070 |
Why?
|
| Coronary Artery Disease | 2 | 2003 | 326 | 0.070 |
Why?
|
| Epigenesis, Genetic | 2 | 2022 | 406 | 0.070 |
Why?
|
| Databases, Factual | 1 | 2012 | 877 | 0.070 |
Why?
|
| Diet Surveys | 2 | 2019 | 44 | 0.070 |
Why?
|
| Aged | 8 | 2018 | 14942 | 0.070 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2015 | 726 | 0.070 |
Why?
|
| Androgens | 1 | 2008 | 66 | 0.070 |
Why?
|
| Leuprolide | 1 | 2008 | 18 | 0.070 |
Why?
|
| Testosterone | 1 | 2008 | 129 | 0.070 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2009 | 460 | 0.070 |
Why?
|
| Micronutrients | 2 | 2018 | 21 | 0.070 |
Why?
|
| Maternal Age | 1 | 2007 | 33 | 0.070 |
Why?
|
| Sperm Injections, Intracytoplasmic | 1 | 2007 | 32 | 0.070 |
Why?
|
| Chemokine CCL3 | 1 | 2007 | 9 | 0.070 |
Why?
|
| Macrophage Inflammatory Proteins | 1 | 2007 | 11 | 0.070 |
Why?
|
| Interleukin 1 Receptor Antagonist Protein | 1 | 2007 | 30 | 0.070 |
Why?
|
| Chemokine CCL4 | 1 | 2007 | 14 | 0.070 |
Why?
|
| Chemokine CCL5 | 1 | 2007 | 33 | 0.070 |
Why?
|
| Chemokine CXCL5 | 1 | 2007 | 9 | 0.070 |
Why?
|
| Interleukins | 1 | 2007 | 83 | 0.070 |
Why?
|
| Chemokines, CXC | 1 | 2007 | 33 | 0.070 |
Why?
|
| Blastocyst | 1 | 2008 | 75 | 0.070 |
Why?
|
| Chemokine CCL2 | 1 | 2007 | 60 | 0.060 |
Why?
|
| Baltimore | 1 | 2007 | 14 | 0.060 |
Why?
|
| Austria | 1 | 2006 | 8 | 0.060 |
Why?
|
| Matched-Pair Analysis | 1 | 2006 | 11 | 0.060 |
Why?
|
| Perimenopause | 1 | 2007 | 32 | 0.060 |
Why?
|
| Hematinics | 1 | 2006 | 11 | 0.060 |
Why?
|
| Drug Combinations | 1 | 2006 | 171 | 0.060 |
Why?
|
| APACHE | 1 | 2005 | 43 | 0.060 |
Why?
|
| Singapore | 1 | 2025 | 14 | 0.060 |
Why?
|
| Parabens | 1 | 2025 | 6 | 0.060 |
Why?
|
| Urban Population | 1 | 2007 | 201 | 0.060 |
Why?
|
| Benzophenones | 1 | 2025 | 20 | 0.060 |
Why?
|
| Fetal Blood | 1 | 2025 | 73 | 0.060 |
Why?
|
| Postmenopause | 1 | 2007 | 239 | 0.060 |
Why?
|
| Fluorocarbons | 1 | 2025 | 50 | 0.060 |
Why?
|
| Benzhydryl Compounds | 1 | 2025 | 61 | 0.060 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2006 | 175 | 0.060 |
Why?
|
| Bisexuality | 1 | 2024 | 15 | 0.060 |
Why?
|
| Sweating | 1 | 2024 | 27 | 0.050 |
Why?
|
| Phenols | 1 | 2025 | 84 | 0.050 |
Why?
|
| Ovarian Diseases | 1 | 2004 | 19 | 0.050 |
Why?
|
| Homosexuality, Female | 1 | 2024 | 22 | 0.050 |
Why?
|
| Seeds | 1 | 2023 | 33 | 0.050 |
Why?
|
| New York | 2 | 2014 | 144 | 0.050 |
Why?
|
| Lipids | 1 | 2005 | 328 | 0.050 |
Why?
|
| Diabetes Complications | 1 | 2003 | 106 | 0.050 |
Why?
|
| Hormone Replacement Therapy | 1 | 2002 | 30 | 0.050 |
Why?
|
| RNA, Ribosomal | 1 | 2022 | 60 | 0.050 |
Why?
|
| Bayes Theorem | 1 | 2022 | 126 | 0.050 |
Why?
|
| Reproductive History | 1 | 2022 | 17 | 0.050 |
Why?
|
| Contraceptives, Oral | 1 | 2021 | 23 | 0.040 |
Why?
|
| Cyclophosphamide | 1 | 2022 | 87 | 0.040 |
Why?
|
| Mexico | 1 | 2021 | 39 | 0.040 |
Why?
|
| Critical Care | 1 | 2005 | 410 | 0.040 |
Why?
|
| Dyspnea | 1 | 2022 | 124 | 0.040 |
Why?
|
| Coronary Disease | 1 | 2002 | 248 | 0.040 |
Why?
|
| Weight Gain | 1 | 2022 | 169 | 0.040 |
Why?
|
| Blood Glucose | 1 | 2023 | 492 | 0.040 |
Why?
|
| Pituitary-Adrenal System | 1 | 2021 | 60 | 0.040 |
Why?
|
| Dried Blood Spot Testing | 1 | 2020 | 3 | 0.040 |
Why?
|
| Glucose | 1 | 2023 | 478 | 0.040 |
Why?
|
| Breast | 1 | 2022 | 193 | 0.040 |
Why?
|
| Hypothalamo-Hypophyseal System | 1 | 2021 | 88 | 0.040 |
Why?
|
| Radiotherapy | 1 | 2020 | 65 | 0.040 |
Why?
|
| Sexuality | 1 | 2020 | 26 | 0.040 |
Why?
|
| Texas | 1 | 2020 | 60 | 0.040 |
Why?
|
| Ovary | 1 | 2020 | 106 | 0.040 |
Why?
|
| Republic of Korea | 1 | 2021 | 199 | 0.040 |
Why?
|
| Asymptomatic Diseases | 1 | 2020 | 49 | 0.040 |
Why?
|
| Insulin | 1 | 2023 | 694 | 0.040 |
Why?
|
| Pain | 1 | 2022 | 403 | 0.040 |
Why?
|
| California | 1 | 2020 | 177 | 0.040 |
Why?
|
| Sterilization, Reproductive | 1 | 2019 | 10 | 0.040 |
Why?
|
| Aged, 80 and over | 3 | 2018 | 5609 | 0.040 |
Why?
|
| Intrauterine Devices | 1 | 2019 | 8 | 0.040 |
Why?
|
| Health Status Disparities | 1 | 2020 | 146 | 0.040 |
Why?
|
| Contraceptive Agents, Female | 1 | 2019 | 24 | 0.040 |
Why?
|
| Vitamin D-Binding Protein | 1 | 2018 | 4 | 0.040 |
Why?
|
| Pregnenes | 1 | 2018 | 1 | 0.040 |
Why?
|
| Sequence Deletion | 1 | 2019 | 116 | 0.040 |
Why?
|
| Contraceptives, Postcoital | 1 | 2018 | 5 | 0.040 |
Why?
|
| Psychological Trauma | 1 | 2018 | 23 | 0.040 |
Why?
|
| Probability | 1 | 2018 | 170 | 0.040 |
Why?
|
| Psychometrics | 1 | 2020 | 392 | 0.030 |
Why?
|
| Lipid Peroxidation | 1 | 2018 | 67 | 0.030 |
Why?
|
| Stearic Acids | 1 | 2017 | 10 | 0.030 |
Why?
|
| Fatty Acids, Monounsaturated | 1 | 2017 | 17 | 0.030 |
Why?
|
| Fatty Acids, Unsaturated | 1 | 2017 | 29 | 0.030 |
Why?
|
| Age of Onset | 1 | 2018 | 175 | 0.030 |
Why?
|
| Survivorship | 1 | 2017 | 14 | 0.030 |
Why?
|
| Laparoscopy | 1 | 2022 | 489 | 0.030 |
Why?
|
| DNA Helicases | 1 | 2019 | 198 | 0.030 |
Why?
|
| United States Department of Veterans Affairs | 1 | 2020 | 567 | 0.030 |
Why?
|
| Blood Pressure Determination | 1 | 2016 | 40 | 0.030 |
Why?
|
| Population Surveillance | 1 | 2017 | 210 | 0.030 |
Why?
|
| Registries | 1 | 2020 | 904 | 0.030 |
Why?
|
| Tooth Loss | 1 | 2015 | 8 | 0.030 |
Why?
|
| Family Planning Services | 1 | 2015 | 21 | 0.030 |
Why?
|
| Dietary Supplements | 1 | 2017 | 239 | 0.030 |
Why?
|
| Health Status | 1 | 2017 | 451 | 0.030 |
Why?
|
| Trauma Severity Indices | 1 | 2014 | 34 | 0.030 |
Why?
|
| Practice Guidelines as Topic | 1 | 2018 | 738 | 0.030 |
Why?
|
| Urinalysis | 1 | 2014 | 37 | 0.030 |
Why?
|
| Rats, Wistar | 1 | 2014 | 187 | 0.030 |
Why?
|
| Healthy Volunteers | 1 | 2014 | 73 | 0.030 |
Why?
|
| Clomiphene | 1 | 2013 | 2 | 0.030 |
Why?
|
| Severity of Illness Index | 2 | 2012 | 1575 | 0.030 |
Why?
|
| Patient Readmission | 1 | 2018 | 446 | 0.030 |
Why?
|
| Child Abuse, Sexual | 1 | 2012 | 25 | 0.020 |
Why?
|
| Drug Administration Schedule | 1 | 2013 | 301 | 0.020 |
Why?
|
| Transportation | 1 | 2012 | 32 | 0.020 |
Why?
|
| Parents | 1 | 2016 | 410 | 0.020 |
Why?
|
| Adaptation, Psychological | 1 | 2014 | 280 | 0.020 |
Why?
|
| Cholesterol, LDL | 1 | 2012 | 104 | 0.020 |
Why?
|
| Double-Blind Method | 1 | 2013 | 749 | 0.020 |
Why?
|
| Child Abuse | 1 | 2012 | 89 | 0.020 |
Why?
|
| Ovulation Prediction | 1 | 2011 | 2 | 0.020 |
Why?
|
| Guidelines as Topic | 1 | 2012 | 162 | 0.020 |
Why?
|
| Linear Models | 1 | 2012 | 409 | 0.020 |
Why?
|
| Rats | 1 | 2014 | 2018 | 0.020 |
Why?
|
| Puerto Rico | 1 | 2011 | 141 | 0.020 |
Why?
|
| Risk Reduction Behavior | 1 | 2011 | 123 | 0.020 |
Why?
|
| Diagnostic Self Evaluation | 1 | 2010 | 23 | 0.020 |
Why?
|
| Waist Circumference | 1 | 2010 | 47 | 0.020 |
Why?
|
| Guideline Adherence | 1 | 2012 | 314 | 0.020 |
Why?
|
| Body Height | 1 | 2010 | 66 | 0.020 |
Why?
|
| Diet Records | 1 | 2009 | 34 | 0.020 |
Why?
|
| Chronic Disease | 1 | 2012 | 757 | 0.020 |
Why?
|
| Infant, Low Birth Weight | 1 | 2009 | 63 | 0.020 |
Why?
|
| Maternal Behavior | 1 | 2009 | 31 | 0.020 |
Why?
|
| Educational Status | 1 | 2010 | 279 | 0.020 |
Why?
|
| Hyperandrogenism | 1 | 2008 | 3 | 0.020 |
Why?
|
| Corpus Luteum | 1 | 2008 | 8 | 0.020 |
Why?
|
| Sample Size | 1 | 2008 | 67 | 0.020 |
Why?
|
| Chorionic Gonadotropin | 1 | 2008 | 15 | 0.020 |
Why?
|
| Embryo Culture Techniques | 1 | 2008 | 12 | 0.020 |
Why?
|
| Treatment Failure | 1 | 2008 | 208 | 0.020 |
Why?
|
| Statistical Distributions | 1 | 2006 | 2 | 0.020 |
Why?
|
| Infant | 1 | 2011 | 1718 | 0.010 |
Why?
|
| Monte Carlo Method | 1 | 2006 | 96 | 0.010 |
Why?
|
| Diagnosis, Differential | 1 | 2008 | 998 | 0.010 |
Why?
|
| Patient Selection | 1 | 2008 | 486 | 0.010 |
Why?
|
| Pilot Projects | 1 | 2008 | 1018 | 0.010 |
Why?
|
| Biomarkers, Tumor | 1 | 2008 | 525 | 0.010 |
Why?
|
| Tomography, X-Ray Computed | 2 | 2003 | 1672 | 0.010 |
Why?
|
| Environmental Monitoring | 1 | 2005 | 153 | 0.010 |
Why?
|
| Los Angeles | 1 | 2002 | 14 | 0.010 |
Why?
|
| Lipoproteins, LDL | 1 | 2002 | 49 | 0.010 |
Why?
|
| Sex Factors | 1 | 2003 | 997 | 0.010 |
Why?
|
| Animals | 1 | 2014 | 21533 | 0.010 |
Why?
|